{"title":"一种UL2缺失鸭肠炎病毒新变体的全基因组序列和生物学特性","authors":"Huan Yang, Bing Zhang, Xiaoyue Yang, Siyuan Hao, Yafen Song, Xiulei Cai, Xiaofei Song, Chenghuai Yang","doi":"10.1007/s00705-025-06408-0","DOIUrl":null,"url":null,"abstract":"<div><p>A virulent duck enteritis virus (DEV) isolate, designated DEV JS2024, was obtained from diseased ducks on a routinely vaccinated duck farm in Jiangsu Province. The complete genome sequence of this isolate was determined and found to be 161,600 bp in length. The UL2 of DEV JS2024 is 474 bp in length and was found to be completely identical to that of a commercially available attenuated DEV vaccine (GenBank accession number KF487736). However, it was found to have a continuous 528-bp deletion when compared with the Chinese standard virulent strain (GenBank accession number JQ673560). In addition, there were point mutations in UL32, UL20, UL14, UL7, RS1, and US5. Ducks infected with DEV JS2024 showed characteristic DEV pathology, including clinical manifestations and pathological lesions. The titer of DEV JS2024 in ducks was 10<sup>5</sup> LD<sub>50</sub>/mL. Our findings suggest that the 528-bp deletion in the UL2 gene is likely to have been generated through recombination between an attenuated vaccine strain and a wild-type virulent strain. This is the first report of a probable natural DEV recombination event identified in the field. . </p></div>","PeriodicalId":8359,"journal":{"name":"Archives of Virology","volume":"170 10","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Complete genome sequence and biological characteristics of a novel duck enteritis virus variant with a deletion in UL2\",\"authors\":\"Huan Yang, Bing Zhang, Xiaoyue Yang, Siyuan Hao, Yafen Song, Xiulei Cai, Xiaofei Song, Chenghuai Yang\",\"doi\":\"10.1007/s00705-025-06408-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>A virulent duck enteritis virus (DEV) isolate, designated DEV JS2024, was obtained from diseased ducks on a routinely vaccinated duck farm in Jiangsu Province. The complete genome sequence of this isolate was determined and found to be 161,600 bp in length. The UL2 of DEV JS2024 is 474 bp in length and was found to be completely identical to that of a commercially available attenuated DEV vaccine (GenBank accession number KF487736). However, it was found to have a continuous 528-bp deletion when compared with the Chinese standard virulent strain (GenBank accession number JQ673560). In addition, there were point mutations in UL32, UL20, UL14, UL7, RS1, and US5. Ducks infected with DEV JS2024 showed characteristic DEV pathology, including clinical manifestations and pathological lesions. The titer of DEV JS2024 in ducks was 10<sup>5</sup> LD<sub>50</sub>/mL. Our findings suggest that the 528-bp deletion in the UL2 gene is likely to have been generated through recombination between an attenuated vaccine strain and a wild-type virulent strain. This is the first report of a probable natural DEV recombination event identified in the field. . </p></div>\",\"PeriodicalId\":8359,\"journal\":{\"name\":\"Archives of Virology\",\"volume\":\"170 10\",\"pages\":\"\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Virology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s00705-025-06408-0\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"VIROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Virology","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00705-025-06408-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"VIROLOGY","Score":null,"Total":0}
Complete genome sequence and biological characteristics of a novel duck enteritis virus variant with a deletion in UL2
A virulent duck enteritis virus (DEV) isolate, designated DEV JS2024, was obtained from diseased ducks on a routinely vaccinated duck farm in Jiangsu Province. The complete genome sequence of this isolate was determined and found to be 161,600 bp in length. The UL2 of DEV JS2024 is 474 bp in length and was found to be completely identical to that of a commercially available attenuated DEV vaccine (GenBank accession number KF487736). However, it was found to have a continuous 528-bp deletion when compared with the Chinese standard virulent strain (GenBank accession number JQ673560). In addition, there were point mutations in UL32, UL20, UL14, UL7, RS1, and US5. Ducks infected with DEV JS2024 showed characteristic DEV pathology, including clinical manifestations and pathological lesions. The titer of DEV JS2024 in ducks was 105 LD50/mL. Our findings suggest that the 528-bp deletion in the UL2 gene is likely to have been generated through recombination between an attenuated vaccine strain and a wild-type virulent strain. This is the first report of a probable natural DEV recombination event identified in the field. .
期刊介绍:
Archives of Virology publishes original contributions from all branches of research on viruses, virus-like agents, and virus infections of humans, animals, plants, insects, and bacteria. Coverage spans a broad spectrum of topics, from descriptions of newly discovered viruses, to studies of virus structure, composition, and genetics, to studies of virus interactions with host cells, organisms and populations. Studies employ molecular biologic, molecular genetics, and current immunologic and epidemiologic approaches. Contents include studies on the molecular pathogenesis, pathophysiology, and genetics of virus infections in individual hosts, and studies on the molecular epidemiology of virus infections in populations. Also included are studies involving applied research such as diagnostic technology development, monoclonal antibody panel development, vaccine development, and antiviral drug development.Archives of Virology wishes to publish obituaries of recently deceased well-known virologists and leading figures in virology.